Doctors in Mumbai are scrambling for new and experimental treatment protocol to ensure faster recovery of patients, with the city emerging as the epicentre of India’s Covid crisis.
This is a race against time to develop health care infrastructure, given the city is fast running out of dedicated Covid-19 isolation wards and intensive care units.
The city administration is pulling out all stops to create Covid-dedicated as well as intensive care beds. On the lines of Wuhan, the Mumbai Metropolitan Region Development Authority (MMRDA) has begun work on a make-shift 1,000-bed mega hospital in the commercial hub of Bandra-Kurla Complex (BKC).
The hospital will serve as an isolation facility for non-critical Covid-19 patients. Expected to be ready in a fortnight, the new makeshift facility can be scaled up to 5,000 beds, if needed. The Brihanmumbai Municipal Corporation (BMC) will run the hospital that will have, among other things, oxygen facilities and pathological laboratories.
A task force comprising nine top doctors has been created to oversee the treatment of patients. From experimenting on biological drugs for skin ailments to rheumatoid arthritis on patients in government hospitals — they have now decided to try a new treatment protocol.
Speaking to Business Standard, Sanjay Oak, member of the task force, said steroids (acting as anti-inflammatory) and low-molecular-weight heparin or LMWH (used in prevention of blood clots) will be given to patients in stage 2b of the disease (or moderate cases). Stages of the disease are mild, moderate, and severe based on symptoms, respiratory rate, and radiological findings.
No comments:
Post a Comment